Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/106572
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy- induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
Author: Roila, F.
Molassiotis, A.
Herrstedt, J.
Aapro, M.
Gralla, R.
Bruera, E.
Clark-Snow, R.
Dupuis, L.
Einhorn, L.
Feyer, P.
Hesketh, P.
Jordan, K.
Olver, I.
Rapoport, B.
Roscoe, J.
Ruhlmann, C.
Walsh, D.
Warr, D.
van der Wetering, M.
on, B.
Citation: Annals of Oncology, 2016; 27(suppl. 5):v119-v133
Publisher: Oxford University Press
Issue Date: 2016
ISSN: 0923-7534
1569-8041
Statement of
Responsibility: 
F. Roila, A. Molassiotis, J. Herrstedt, M. Aapro, R. J. Gralla, E. Bruera, R. A. Clark-Snow, L. L. Dupuis, L. H. Einhorn, P. Feyer, P. J. Hesketh, K. Jordan I. Olver, B. L. Rapoport, J. Roscoe, C. H. Ruhlmann, D. Walsh, D. Warr, M. van der Wetering on behalf of the participants of the MASCC/ESMO Consensus Conference Copenhagen 2015
Abstract: Despite the considerable progress achieved in the last 30 years, vomiting and, especially, nausea, continue to be two of the most distressing side-effects of cancer chemotherapy. In the late 1990s, several professional organisations published recommendations on the optimal antiemetic prophylaxis in patients submitted to chemotherapy and/or radiotherapy. The European Society of Medical Oncology (ESMO) and the Multinational Association of Supportive Care in Cancer (MASCC) published the results of the third Consensus Conference on antiemetics held in Perugia in June 2009 in Annals of Oncology in 2010 [1]. An update of these recommendations, including studies published from 1 January 2009 to 30 June 2015, was discussed in Copenhagen in June 2015 and is presented in this paper. The methodology for the guideline process is described in detail in the 2010 publication [1]. To change a 2010 recommendation or for a new guideline recommendation to be accepted, a consensus of at least 67% of the expert panellists was needed. As a general rule, the panel considered changes of 10% or greater to be sufficient to warrant the changing of a recommendation.
Keywords: participants of the MASCC/ESMO Consensus Conference Copenhagen 2015
Rights: Copyright © 2017 European Society for Medical Oncology
RMID: 0030061383
DOI: 10.1093/annonc/mdw270
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.